This list is an analysis based on recent market events. It's not an investment recommendation.
About
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
What is Indivior Pharmaceuticals stock price today?▼
The current price of E7P.MU is €31.00 EUR — it has increased by +0% in the past 24 hours. Watch Indivior Pharmaceuticals stock price performance more closely on the chart.
What is Indivior Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Indivior Pharmaceuticals stocks are traded under the ticker E7P.MU.
What is Indivior Pharmaceuticals market cap?▼
Today Indivior Pharmaceuticals has the market capitalization of 159.43M
What is Indivior Pharmaceuticals revenue for the last year?▼
Indivior Pharmaceuticals revenue for the last year amounts to 1.07B EUR.
What is Indivior Pharmaceuticals net income for the last year?▼
E7P.MU net income for the last year is 182.28M EUR.
In which sector is Indivior Pharmaceuticals located?▼
Indivior Pharmaceuticals operates in the Other sector.
When did Indivior Pharmaceuticals complete a stock split?▼
Indivior Pharmaceuticals has not had any recent stock splits.